Showing results (1631-1640 of 2,364) with videos related to
Sort By:
Pageof 237
Circulation|November 12, 2003
Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromesKenichi Fujii, Yoshio Kobayashi, Gary S Mintz, et al.The American Journal of Cardiology|November 13, 2001
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial)B R Brodie, G W Stone, M C Morice, et al.American Heart Journal|August 10, 2005
Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisitedGiora Weisz, David A Cox, Eulogio Garcia, et al.The American Journal of Cardiology|October 22, 2008
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials)Jiro Aoki, Gary S Mintz, Neil J Weissman, et al.Journal of the American College of Cardiology|March 21, 2020
Health Status Changes and Outcomes in Patients With Heart Failure and Mitral Regurgitation: COAPT TrialSuzanne V Arnold, Gregg W Stone, Michael J Mack, et al.JACC. Cardiovascular Imaging|August 24, 2020
Regurgitant Volume/Left Ventricular End-Diastolic Volume Ratio: Prognostic Value in Patients With Secondary Mitral RegurgitationFarnaz Namazi, Pieter van der Bijl, Federico Fortuni, et al.JACC. Cardiovascular Interventions|October 28, 2025
Revascularization in Ischemic Left Ventricular Dysfunction: A Pathophysiology-Guided, Evidence-Based ApproachMatthew Ryan, Alexander G Truesdell, Gavin J Murphy, et al.Plos Medicine|July 23, 2025
Analysis of inter-hospital transfer on clinical outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A secondary analysis of the BRIGHT-4 trialXiaolin Su, Miaohan Qiu, Chengqi Gu, et al.European Heart Journal|July 15, 2015
Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: A consensus document from the Mitral Valve Academic Research ConsortiumGregg W Stone, David H Adams, William T Abraham, et al.European Heart Journal|September 12, 2018
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trialGregg W Stone, Philippe Généreux, Robert A Harrington, et al.Pageof 237